HEALTH (ALT)

KWN HEALTH

HEALTH (MSM)

Countries must invest more in mental health in hard times: WHO

By Stephanie Nebehay GENEVA (Reuters) – Rich and poor countries alike must invest more in mental health care, especially during economic crises when rates of depression and suicide tend to rise, the World Health Organization (WHO)said on Tuesday. One in 10 people worldwide has a mental health disorder but only one percent of the global health workforce is treating such illnesses, which are still widely stigmatized, the United Nations agency

U.S. consumer groups oppose Teva bid for generic drug rival Mylan

A proposed merger of the two largest U.S. generic drug makers drew fire on Tuesday from Consumers Union and seven other groups, who asked antitrust enforcers to stop Teva Pharmaceutical Industries Ltd’s proposal to purchase Mylan NV , saying it would lead to higher prices and more drug shortages. Mylan has been rebuffing Teva’s takeover bids, including one in April for $40 billion. Meanwhile, Mylan has pressed on with a

New U.N. goals lack focus, global health experts warn

(This June 24 story corrects source’s name to Christopher Murray in paragraph 8.) By Stella Dawson WASHINGTON (Thomson Reuters Foundation) – Shrinking aid dollars threaten the major advances made over the past decade in fighting disease and preventable deaths, a task that will grow even more difficult under new United Nations’ development goals, experts in global health said. Child mortality has plunged since the U.N. set a development goal of

Up to 1.3 million in parched Ukraine face water crisis: UNICEF

By Magdalena Mis LONDON (Thomson Reuters Foundation) – Up to 1.3 million people in war-torn eastern Ukraine are facing acute water shortages and a serious water crisis due to damaged or destroyed infrastructure, the United Nations children’s agency UNICEF said on Tuesday. In Mariupol, a city of 500,000 in the Donetsk region, they rely on water from a “rapidly depleting” reservoir, UNICEF said. “Water is one of the most acute

Zogenix delays epilepsy drug trials by three months

(Reuters) – Drug developer Zogenix Inc said on Tuesday that it would push back late-stage trials of its treatment for a rare form of epilepsy by about three months to enroll more patients. The company said it now planned to begin late-stage trials of the drug, ZX008, in the fourth quarter, and would seek to enroll 105 patients in the studies, up from 40 to 60 earlier, acting on guidance

New heart drug guidelines efficient and cost effective

By Andrew M. Seaman (Reuters Health) – New guidelines for prescribing cholesterol-lowering medications are efficient and cost-effective, according to two new studies. The new research, published in JAMA, examines the 2013 recommendation that people ages 40 to 75 with at least a 7.5 percent risk of having a heart attack or stroke over the next 10 years receive statin drugs. “We decide to look at this, because we felt it

Colorado cinema massacre trial to hear closing arguments

By Keith Coffman CENTENNIAL, Colo. (Reuters) – Lawyers in the trial of Colorado movie massacre gunman James Holmes will make their closing arguments on Tuesday to jurors who must decide whether he is a calculating mass murderer or was legally insane when he killed 12 people. Prosecutors and the defense have been allotted two hours each to present their case by Arapahoe County District Court Judge Carlos Samour, after testimony